UPC CFI 701/2024
Nov 19, 2024·EP2077811 · CLAY-BASED HEMOSTATIC AGENTS AND DEVICES FOR THE DELIVERY THEREOF
Action number: ACT 61342/2024
- Case details
- StatusCase ClosedActionProvisional measuresCategoryProvisional measures
- Parties
- Claimants
- Teleflex Life Sciences II LLCOperating co.
Representatives- Ulrich Blumenröder-Grünecker Patent- und Rechtsanwälte PartGmbH
- Sebastian Ochs-Grünecker Patent- und Rechtsanwälte PartGmbH
- Elvira Bertram-Grünecker Patent- und Rechtsanwälte PartGmbH
- Thomas Laubenthal-Grünecker Patent- und Rechtsanwälte PartGmbH
- Alexander Stumvoll-Grünecker Patent- und Rechtsanwälte PartGmbH
Respondents- Speed Care Mineral GmbHOperating co.
Representatives- Alexander Reetz-Wildanger Kehrwald Graf von Schwerin & Partner mbB
- Peter-Michael Weisse-Wildanger Kehrwald Graf von Schwerin & Partner mbB
- Eva-Maria Thörner-Wildanger Kehrwald Graf von Schwerin & Partner mbB
- Jan-Caspar Maiers-Wildanger Kehrwald Graf von Schwerin & Partner mbB
- Division
- Hamburg LD
- Technology
- InstrumentsMedical technology
- Language
- English
- First decided
- Feb 21, 2025
- EPO Opposition
- CARL FREUDENBERG KG Patente und Marken2011-08-04
| Preliminary injunction granted | Median days to first decision | |
|---|---|---|
| All UPC | 54% (38/70) | 124 |
| Hamburg LD | Locked | Locked |
| Judge Sabine Klepsch | Locked | Locked |
| Judge Stefan Johansson | Locked | Locked |
| Judge Stefan Schilling | Locked | Locked |
| Judge Jeroen Meewisse | Locked | Locked |
At the UPC: Teleflex Life Sciences II LLC (6 cases)·Speed Care Mineral GmbH (6 cases)
This dispute contains 5 other proceedings
UPC CoA 85/2026·UPC CFI 235/2025·UPC CFI 157/2025·UPC CFI 685/2024·UPC CFI 1849/2026
Start a free trial to see how each one ended.
More cases: Hamburg LD·2024
- 2025-02-21Application for provisional measuresPublic
Summary: The Hamburg Local Division dismissed Teleflex Life Sciences II LLC's application for provisional measures against Speed Care Mineral GmbH regarding hemostatic wound-care products, because Teleflex failed to demonstrate with sufficient certainty that the attacked embodiment contained a 'binder' as required by the patent claims, and the burden of proof was not reversed.
Show the legal issues (3)
- Burden of proof for patent infringement in provisional measures proceedings
- Reversal of burden of proof threshold under Art. 62(2) UPCA and R. 209(2) RoP
- Sufficiency of evidence for presence of claimed 'binder' element
| Document title | Date | Public |
|---|---|---|
| FInalOrder | 2025-02-21 | Not public |
| Headnote-and-Keywords | 2025-02-21 | Not public |
| Measures_DecisionOutcome_Notification.pdf | 2025-02-21 | Not public |
| Order with grounds | 2025-02-21 | Not public |
| Order with grounds | 2025-02-21 | Public |
| Template-Order | 2025-02-21 | Not public |
| Order with grounds | 2025-02-21 | Not public |
| Closing workflow (ORD_5952_2025) | 2025-02-04 | Not public |
| Outcome of the Order | 2025-02-04 | Not public |
| Closing workflow | 2025-02-04 | Public |
| Outcome of the Order | 2025-02-04 | Not public |
| Closing workflow | 2025-02-04 | Public |
| Recording | 2025-01-30 | Not public |
| Recording | 2025-01-30 | Not public |
| Receipt | 2025-01-29 | Not public |
| WKS H 13 | 2025-01-28 | Not public |
| 20250128_Exhibits_Oral_hearing | 2025-01-28 | Not public |
| Outcome of the Order | 2025-01-28 | Not public |
| Anordnung | 2025-01-28 | Public |
| Anordnung | 2025-01-28 | Public |
| Receipt | 2025-01-28 | Not public |
| 20250127_Request_R262A | 2025-01-27 | Not public |
| WKS_16' (unredacted) | 2025-01-27 | Not public |
| WKS_14' (unredacted) | 2025-01-27 | Not public |
| WKS_15' (unredacted) | 2025-01-27 | Not public |
| WKS_17' (unredacted) | 2025-01-27 | Not public |
| 20270127_App_RoP9_Confidential_Exhibits | 2025-01-27 | Not public |
| WKS_17' (unredacted) | 2025-01-27 | Not public |
| WKS_14' (unredacted) | 2025-01-27 | Not public |
| WKS_16' (unredacted) | 2025-01-27 | Not public |
| WKS_15' (unredacted) | 2025-01-27 | Not public |
| WKS 19 Supplementary Testimony Montag | 2025-01-16 | Not public |
| WKS 17 Statement Wound Dressing Manufacturer (redacted) | 2025-01-16 | Not public |
| WKS 18 Supplementary Testimony Kruse.pdf | 2025-01-16 | Not public |
| WKS H 12 N5 (EP0116240A1) | 2025-01-16 | Not public |
| WKS 20 Supplementary Heppe Report | 2025-01-16 | Not public |
| WKS 16 Statement Halloysite Supplier (redacted).pdf | 2025-01-16 | Not public |
| WKS 21 Supplementary Testimony Pommerening | 2025-01-16 | Not public |
| WKS H 12 N5 (EP0116240A1) | 2025-01-16 | Not public |
| WKS Statement Fiber Supplier (redacted).pdf | 2025-01-16 | Not public |
| WKS 15 Statement Gauze Supplier (redacted) | 2025-01-16 | Not public |
| 20250116 Speed Care Mineral vs Teleflex - Rejoinder - UPC_CFI_701/2024 | 2025-01-16 | Not public |
| WKS H 11 | 2025-01-16 | Not public |
| Annex K39 | 2025-01-06 | Not public |
| Annex K47-EN | 2025-01-06 | Not public |
| Annex K48 | 2025-01-06 | Not public |
| Annex K38 | 2025-01-06 | Not public |
| Annex K50 | 2025-01-06 | Not public |
| Annex K51 | 2025-01-06 | Not public |
| Annex K35 | 2025-01-06 | Not public |
| Annex K39-EN | 2025-01-06 | Not public |
| Annex K42 | 2025-01-06 | Not public |
| Annex K32 | 2025-01-06 | Not public |
| Annex K47 | 2025-01-06 | Not public |
| Annex K33 | 2025-01-06 | Not public |
| Annex K46 | 2025-01-06 | Not public |
| Annex K45 | 2025-01-06 | Not public |
| Annex K34 | 2025-01-06 | Not public |
| Annex K49 | 2025-01-06 | Not public |
| Annex K41 | 2025-01-06 | Not public |
| Annex K36 | 2025-01-06 | Not public |
| Annex K44 | 2025-01-06 | Not public |
| Annex K43 | 2025-01-06 | Not public |
| Annex K37 | 2025-01-06 | Not public |
| Annex K40-EN | 2025-01-06 | Not public |
| Annex K40 | 2025-01-06 | Not public |
| Annex K38-EN | 2025-01-06 | Not public |
| Replik EV | 2025-01-06 | Not public |
| Annex K35-EN | 2025-01-06 | Not public |
| Annex K36-EN | 2025-01-06 | Not public |
| Panel-Appointment | 2025-01-03 | Not public |
| Anordnung | 2024-12-26 | Public |
| Template-Order | 2024-12-26 | Not public |
| Acknowledgement-of-lodging | 2024-12-23 | Not public |
| WKS 1 - D3 | 2024-12-23 | Not public |
| WKS H8 - WO479 | 2024-12-23 | Not public |
| WKS H5 - D12 | 2024-12-23 | Not public |
| WKS DE - German version | 2024-12-23 | Not public |
| WKS 13i - Register IT | 2024-12-23 | Not public |
| WKS H3 - EP051 | 2024-12-23 | Not public |
| WKS 13c - Register DE | 2024-12-23 | Not public |
| WKS 10 - Written testimony Ulf Pommerening | 2024-12-23 | Not public |
| WKS 2 - Römpp: Hydratisierung, Hydratation | 2024-12-23 | Not public |
| WKS 9 - Heppe Report | 2024-12-23 | Not public |
| WKS 11 - EU QMS Certificate | 2024-12-23 | Not public |
| WKS 13a - Register NL | 2024-12-23 | Not public |
| WKS 13b - Register BE | 2024-12-23 | Not public |
| WKS 4 - Joussein et al., 2006 | 2024-12-23 | Not public |
| WKS 7 - Written testimony Siegfried Kruse | 2024-12-23 | Not public |
| WKS 13j - Register SE | 2024-12-23 | Not public |
| WKS H9 - WO008 | 2024-12-23 | Not public |
| WKS H3 - EP051 | 2024-12-23 | Not public |
| WKS 5 - Römpp, Halloysit | 2024-12-23 | Not public |
| WKS 12 - LD Düsseldorf - UPC_CFI_486/2024 (redacted) | 2024-12-23 | Not public |
| WKS 6 - Hunnius, Quelltone | 2024-12-23 | Not public |
| WKS 13b - Register BE | 2024-12-23 | Not public |
| WKS H1 - Guar gum | 2024-12-23 | Not public |
| WKS 8 - Written testimony Susanne Montag | 2024-12-23 | Not public |
| WKS H4 - D11 | 2024-12-23 | Not public |
| WKS 13i - Register IT | 2024-12-23 | Not public |
| WKS 13f - Register FI | 2024-12-23 | Not public |
| WKS 13e - Register DK | 2024-12-23 | Not public |
| WKS 13h - Register PT | 2024-12-23 | Not public |
| WKS 13e - Register DK | 2024-12-23 | Not public |
| WKS H6 - WO326 | 2024-12-23 | Not public |
| WKS 13d - Register AT | 2024-12-23 | Not public |
| 20241223 Teleflex-Speed Care Mineral - Objection - RoP 209 | 2024-12-23 | Not public |
| WKS 3 - Jasmund/Lagaly, Table 2.1 | 2024-12-23 | Not public |
| WKS 13d - Register AT | 2024-12-23 | Not public |
| WKS 13h - Register PT | 2024-12-23 | Not public |
| WKS H7 - Prio WO326 | 2024-12-23 | Not public |
| WKS H2 - Polyvinylalkohol | 2024-12-23 | Not public |
| WKS 13g - Register FR | 2024-12-23 | Not public |
| Summon-Oral-Hearing | 2024-12-18 | Not public |
| oral hearing | 2024-12-18 | Public |
| Opposition | 2024-11-27 | Public |
| Anhoerung | 2024-11-22 | Public |
| Template-Order | 2024-11-22 | Not public |
| Template-Order | 2024-11-22 | Not public |
| Comments to Procedural Order | 2024-11-22 | Not public |
| Anhoerung | 2024-11-22 | Not public |
| Panel-Appointment | 2024-11-22 | Not public |
| Anhoerung | 2024-11-21 | Public |
| Panel-Appointment | 2024-11-21 | Not public |
| Application-For-Measures-Receipt | 2024-11-21 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2024-11-21 | Not public |
| Application-For-Measures-Acknowledgement | 2024-11-18 | Not public |
| Annex K5 | 2024-11-18 | Not public |
| Annex K29 | 2024-11-18 | Not public |
| Annex K4 | 2024-11-18 | Not public |
| Annex K21 | 2024-11-18 | Not public |
| Annex K27 | 2024-11-18 | Not public |
| Annex K13 | 2024-11-18 | Not public |
| Annex K8 | 2024-11-18 | Not public |
| Annex K20b | 2024-11-18 | Not public |
| Annex K12 | 2024-11-18 | Not public |
| Annex K7 | 2024-11-18 | Not public |
| Annex K19 | 2024-11-18 | Not public |
| Annex K10 | 2024-11-18 | Not public |
| Annex K28 | 2024-11-18 | Not public |
| Annex K3 | 2024-11-18 | Not public |
| Annex K9 | 2024-11-18 | Not public |
| Annex K18 | 2024-11-18 | Not public |
| Annex K25 | 2024-11-18 | Not public |
| Annex K23 | 2024-11-18 | Not public |
| Annex K17 | 2024-11-18 | Not public |
| Annex K1 | 2024-11-18 | Not public |
| Annex K20 | 2024-11-18 | Not public |
| Annex K24 | 2024-11-18 | Not public |
| Annex K24a | 2024-11-18 | Not public |
| Annex K14 | 2024-11-18 | Not public |
| Annex K2 | 2024-11-18 | Not public |
| Annex K13-EN | 2024-11-18 | Not public |
| Annex K16 | 2024-11-18 | Not public |
| Annex K15 | 2024-11-18 | Not public |
| Annex K6 | 2024-11-18 | Not public |
| Annex K11 | 2024-11-18 | Not public |
| Annex K31 | 2024-11-18 | Not public |
| Annex K16a | 2024-11-18 | Not public |
| Annex K22 | 2024-11-18 | Not public |
| Annex K20a | 2024-11-18 | Not public |
| Annex K26 | 2024-11-18 | Not public |
| Annex K30 | 2024-11-18 | Not public |
| Urgent Motion for Preliminary Injunction | 2024-11-18 | Not public |
Teleflex Life Sciences applied for a preliminary injunction against Speed Care Mineral's hemostatic wound-care products based on EP 2 077 811. The Hamburg Local Division dismissed the application because Teleflex failed to demonstrate with the required certainty that the attacked product contained a 'binder' as claimed, and the burden of proof was not reversed in the applicant's favour. Since infringement could not be established, the court did not need to assess patent validity or other PI requirements.
Burden of proof for patent infringement lies with applicant and is not reversed without sufficient prior indication of infringement
RespondentLegal basis: Art. 62(2) UPCA; Rule 209(2) RoPNote: The Hamburg Local Division confirmed that the standard burden of proof on the applicant to establish infringement was not reversed in this case because Teleflex had not provided reasonable indications that the accused product contained a 'binder' as required by the claims.
Attacked embodiment (Speed Care hemostatic gauze) contains a binder as required by patent claims
ClaimantLegal basis: EP 2 077 811Reason: Teleflex failed to demonstrate with sufficient certainty that the attacked product contains a binder; the defendant's evidence (scanning electron microscope images from University of Greifswald) showed mechanical adhesion of halloysite to cellulose fiber without a binder, and Teleflex presented no contradicting evidence.
Burden of proof should be reversed because applicant has provided reasonable indications of infringement
ClaimantLegal basis: Rule 209(2) RoPReason: The court found that the applicant's evidence was insufficient to constitute 'reasonable indications and/or facts' that would reverse the burden of proof.
The central claim construction issue was the meaning of 'binder' in EP 2 077 811 (clay-based hemostatic agents). The court did not resolve this definitively because it found infringement not proven regardless: the defendant argued that halloysite nanotubes mechanically adhere to the Lyocell carrier via interlacing and electrostatic processes without a binder, and Teleflex could not disprove this.